Fujian Shengdi Pharmaceutical Co.

SEP 10, 2026 · PHASE 1 TRIAL

A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants

ClinicalTrials.gov

Phase 1 open-label mass balance study in a small healthy cohort (n=6) designed to characterize drug disposition, not efficacy or safety, with no results yet reported in this registry record.

SEP 8, 2026 · PHASE 1 TRIAL

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

ClinicalTrials.gov

Phase 1 single-dose pharmacokinetic study in a small, planned cohort with no results yet posted; registry record only describes the protocol.

AUG 13, 2026 · PHASE 3 TRIAL

A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

ClinicalTrials.gov

This is a registry record of a Phase 3 RCT currently recruiting, with no posted results; the study design is sound but evidence cannot be assessed until outcomes are reported.

JUL 31, 2026 · PHASE 1 TRIAL

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

ClinicalTrials.gov

Phase 1 trial in recruitment with no results posted; establishes only planned design and safety endpoints in adolescents with obesity.